1 |
Yu, J. M., Kim, D. H. and Son, J. H. 2015. Whitening effects of solvent fractions isolated from Vitex rotundifolia. J. Appl. Biol. Chem. 58, 266-271.
|
2 |
Yoshioka, T., Inokuchi, T., Fujioka, S. and Kimura, Y. 2004. Phenolic compounds and flavonoids as plant growth regulators from fruit and leaf of Vitex rotundifolia. Z. Naturforsch. 59, 509-514.
|
3 |
Cathcart, J., Pulkoski-Gross, A. and Cao, J. 2015. Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas. Genes Dis. 2, 26-34.
DOI
|
4 |
Eugenia Gentile, E. and Liuzzi, G. M. 2017. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation. Drug Discov. Today 22, 299-313.
DOI
|
5 |
Gialeli, C., Theocharis, A. D. and Karamanos, N. K. 2011. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278, 16-27.
DOI
|
6 |
Hadler-Olsen, E., Fadnes, B., Sylte, I., Uhlin-Hansen, L. and Winberg, J. O. 2011. Regulation of matrix metalloproteinases in health and disease. FEBS J. 278, 28-45.
|
7 |
Hansen, M. B., Nielsen, S. E. and Berg, K. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Meth. 119, 203-210.
DOI
|
8 |
Hu, J., Van den Steen, P. E. and Sang, Q. X. A. and Opdenakker, G. 2007. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 6, 480-498.
DOI
|
9 |
Mignatti, P. and Fifkin, D. B. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195.
|
10 |
Kieseier, B. C., Seifert, T., Giovannoni, G. and Hartung, H. P. 1999. Matrix metalloproteinases in inflammatory demyelination. Neurology 53, 20-25.
DOI
|
11 |
Moss, L. A. S., Jensen-Taubman, S. and Stetler-Stevenson, W. G. 2012. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am. J. Pathol. 181, 1895-1899.
DOI
|
12 |
Sang, Q. X., Jin, Y., Newcomer, R. G., Monroe, S. C., Fang, X. X., Hurst, D. R., Lee, S., Cao, Q. and Schwartz, M. A. 2006. Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases. Curr. Top. Med. Chem. 6, 289-316.
DOI
|
13 |
Shay, G., Lynch, C. C. and Fingleton, B. 2015. Moving targets: emerging roles for MMPs in cancer progression and metastasis. Matrix Biol. 44-46, 200-206.
DOI
|
14 |
Sternlicht, M. D. and Werb, Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17, 463-516.
DOI
|
15 |
Stocker, W, Grams, F., Reinemer, P., Bode, W., Baumann, U., Gomis-Ruth. F. X. and Mckay, D. D. 1995. The metzincins- topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 4, 823-840.
|
16 |
Verma, R. P. and Hansch, C. 2007 Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs. Bioorg. Med. Chem. 15, 2223-2268.
DOI
|
17 |
You, J. S., Chae, B. S., Kim, D. K., Cui, X., Park, J. S., Lee, J. H., Kim, S. H. and Shin, T. Y. 2013. Antiallergic and anti- inflammatory effects of the viticis fructus. Kor. J. Pharmacogn. 44, 286-290.
|